Is Invesco S&P 500 Pure Value ETF (RPV) a Strong ETF Right Now?

The Invesco S&P 500 Pure Value ETF (RPV), a smart beta large-cap value fund tracking the S&P 500 Pure Value Index, manages over $1.36 billion with a 0.35% expense ratio. RPV has shown robust performance, gaining 11.87% year-to-date and 13.54% over the past year (as of 10/31/2025), exhibiting a medium-risk profile. The fund's portfolio is primarily allocated to Healthcare, Financials, and Consumer Staples, but investors should note that competing value ETFs like SCHD and VTV offer substantially lower expense ratios.

Analysis

The Invesco S&P 500 Pure Value ETF (RPV), a smart beta large-cap value fund, has demonstrated robust performance, achieving an 11.87% year-to-date gain and a 13.54% return over the past year as of October 31, 2025. Managing over $1.36 billion in assets, RPV tracks the S&P 500 Pure Value Index and is characterized as a medium-risk option, exhibiting a beta of 0.96 and a 16.91% standard deviation over the trailing three-year period.

The fund maintains a diversified portfolio of 106 holdings, with its heaviest sector allocations in Healthcare (18.2%), followed by Financials and Consumer Staples. Key individual holdings include CVS Health Corp (3.45%), General Motors Co, and Ford Motor Co, with the top 10 holdings collectively accounting for 24.85% of total assets. RPV also offers a 12-month trailing dividend yield of 2.57%.

However, RPV's annual operating expense ratio stands at 0.35%, which is notably higher than direct competitors in the large-cap value segment. For instance, Schwab U.S. Dividend Equity ETF (SCHD) and Vanguard Value ETF (VTV) offer significantly lower expense ratios of 0.06% and 0.04% respectively, while managing substantially larger asset bases of $69.1 billion and $148.72 billion. This cost differential is a material consideration for long-term investment returns.

While RPV's smart beta approach aims for superior stock selection, the higher expense ratio compared to traditional market-cap weighted value ETFs could erode potential outperformance over time. Its specific sector concentration and individual holdings should be weighed against broader market value exposure offered by lower-cost alternatives.

Key Decisions for Investors

• Investors should weigh RPV's recent strong performance and medium-risk profile against its 0.35% expense ratio, which is significantly higher than competing large-cap value ETFs.
• Consider the long-term impact of expense ratios by comparing RPV to lower-cost alternatives like SCHD (0.06%) and VTV (0.04%) for similar large-cap value exposure.
• Evaluate whether RPV's smart beta methodology and specific sector allocations (Healthcare, Financials, Consumer Staples) provide sufficient alpha potential to justify its higher fee structure.